Identification of Risk Factors to Predict the Occurrences of Relapses in Individuals with Schizophrenia Spectrum Disorder in Iran.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
11 01 2021
Historique:
received: 16 11 2020
revised: 29 12 2020
accepted: 31 12 2020
entrez: 14 1 2021
pubmed: 15 1 2021
medline: 19 3 2021
Statut: epublish

Résumé

Schizophrenia Spectrum Disorder (SSD) is a chronic psychiatric disorder with a modest treatment outcome. In addition, relapses are commonplace. Here, we sought to identify factors that predict relapse latency and frequency. To this end, we retrospectively analyzed data for individuals with SSD. Medical records of 401 individuals with SSD were analyzed (mean age: 25.51 years; 63.6% males) covering a five-year period. Univariate and multivariate Penalized Likelihood Models with Shared Log-Normal Frailty were used to determine the correlation between discharge time and relapse and to identify risk factors. A total of 683 relapses were observed in males, and 422 relapses in females. The Relapse Hazard Ratio (RHR) decreased with age (RHR = 0.99, CI: (0.98-0.998)) and with participants' adherence to pharmacological treatment (HR = 0.71, CI: 0.58-0.86). In contrast, RHR increased with a history of suicide attempts (HR = 1.32, CI: 1.09-1.60), and a gradual compared to a sudden onset of disease (HR = 1.45, CI: 1.02-2.05). Gender was not predictive. Data indicate that preventive and therapeutic interventions may be particularly important for individuals who are younger at disease onset, have a history of suicide attempts, have experienced a gradual onset of disease, and have difficulties adhering to medication.

Identifiants

pubmed: 33440817
pii: ijerph18020546
doi: 10.3390/ijerph18020546
pmc: PMC7827717
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Perspect Psychiatr Care. 2020 Jul;56(3):564-573
pubmed: 31868231
PLoS One. 2017 Sep 21;12(9):e0183998
pubmed: 28934214
Australas Psychiatry. 2016 Feb;24(1):49-54
pubmed: 26139698
J Psychiatr Res. 2020 Sep;128:75-82
pubmed: 32535343
Lancet Psychiatry. 2020 Sep;7(9):749-761
pubmed: 32828165
Jpn J Nurs Sci. 2019 Jan;16(1):62-70
pubmed: 29749105
Schizophr Bull. 2018 Apr 6;44(3):603-619
pubmed: 29868849
Eur Psychiatry. 2018 Oct;54:124-144
pubmed: 30257806
J Psychiatr Res. 2020 Oct;129:222-233
pubmed: 32805530
Front Psychiatry. 2016 Aug 02;7:125
pubmed: 27531983
BMC Psychiatry. 2016 Apr 06;16:90
pubmed: 27048373
J Clin Hypertens (Greenwich). 2008 May;10(5):348-54
pubmed: 18453793
Med Care. 1986 Jan;24(1):67-74
pubmed: 3945130
Epidemiol Rev. 1995;17(1):10-20
pubmed: 8521927
Neuropsychobiology. 2017;76(1):51-58
pubmed: 29649810
Arch Iran Med. 2015 Feb;18(2):74-5
pubmed: 25644793
Schizophr Res. 2018 Dec;202:26-36
pubmed: 30005933
Int J Neuropsychopharmacol. 2020 Apr 21;23(3):192-205
pubmed: 31781761
Biol Psychiatry. 2011 Jul 1;70(1):88-96
pubmed: 21457946
Clin Psychopharmacol Neurosci. 2018 Nov 30;16(4):361-375
pubmed: 30466208
Lancet Psychiatry. 2014 Jun;1(1):73-85
pubmed: 26360404
World Psychiatry. 2017 Oct;16(3):308-315
pubmed: 28941119
Clin Pract Epidemiol Ment Health. 2005 Sep 26;1:16
pubmed: 16185355
World J Psychiatry. 2015 Sep 22;5(3):255-9
pubmed: 26425440
Compr Psychiatry. 2017 Aug;77:71-79
pubmed: 28636896
Eur Psychiatry. 2012 Jan;27(1):9-18
pubmed: 21561742
Psychiatry Res. 2015 Jan 30;225(1-2):14-30
pubmed: 25466227
N Engl J Med. 1999 Feb 25;340(8):603-8
pubmed: 10029644
Schizophr Res. 2018 Mar;193:412-417
pubmed: 28637633
BMC Psychiatry. 2018 Sep 18;18(1):300
pubmed: 30227840
Iran J Psychiatry. 2015 Apr;10(2):123-7
pubmed: 26884789
Mol Psychiatry. 2015 Jun;20(6):671-6
pubmed: 25824303
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Prog Neurobiol. 2012 Jan;96(1):46-68
pubmed: 22120173
Curr Med Res Opin. 2014 Aug;30(8):1643-55
pubmed: 24730586
Int J Ment Health Nurs. 2014 Dec;23(6):490-7
pubmed: 25279684
J Abnorm Psychol. 2019 Nov;128(8):840-854
pubmed: 31343181
Nat Rev Dis Primers. 2015 Nov 12;1:15067
pubmed: 27189524
Schizophr Bull. 2015 May;41(3):574-83
pubmed: 25800248
BMC Psychiatry. 2013 Feb 08;13:50
pubmed: 23394123
Schizophr Bull. 2016 May;42(3):588-99
pubmed: 26547223
J Neurol Neurosurg Psychiatry. 2005 Mar;76 Suppl 1:i53-60
pubmed: 15718223
BMC Public Health. 2013 Jan 04;13:4
pubmed: 23289631
Aust N Z J Psychiatry. 2019 Jun;53(6):509-527
pubmed: 30957510
Psychol Rev. 2016 Apr;123(3):235-54
pubmed: 26524155
Qual Health Res. 2018 May;28(6):987-1001
pubmed: 29478404
Schizophr Bull. 2014 Jan;40(1):192-213
pubmed: 23256986
J Clin Psychol. 2006 Feb;62(2):185-200
pubmed: 16342288
Am J Med. 2012 Sep;125(9):888-96
pubmed: 22800876
Cochrane Database Syst Rev. 2015 Apr 09;(4):CD010823
pubmed: 25854522
Schizophr Res. 2018 Feb;192:124-130
pubmed: 28499766
Int J Environ Res Public Health. 2020 Aug 27;17(17):
pubmed: 32867189

Auteurs

Omran Davarinejad (O)

Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6719851115, Iran.
Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah 6719851451, Iran.

Tahereh Mohammadi Majd (T)

Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah 6719851451, Iran.

Farzaneh Golmohammadi (F)

Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah 6719851451, Iran.

Payam Mohammadi (P)

Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah 6719851451, Iran.

Farnaz Radmehr (F)

Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah 6719851451, Iran.

Mostafa Alikhani (M)

Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6719851115, Iran.
Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah 6719851451, Iran.

Tayebeh Motaei (T)

Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah 6719851451, Iran.

Mehdi Moradinazar (M)

Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah 6719851451, Iran.

Annette Brühl (A)

Center for Affective, Stress and Sleep Disorders (ZASS), University of Basel, 4002 Basel, Switzerland.

Dena Sadeghi Bahmani (D)

Center for Affective, Stress and Sleep Disorders (ZASS), University of Basel, 4002 Basel, Switzerland.
Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah 6719851115, Iran.
Departments of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL 35209, USA.

Serge Brand (S)

Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6719851115, Iran.
Center for Affective, Stress and Sleep Disorders (ZASS), University of Basel, 4002 Basel, Switzerland.
Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah 6719851115, Iran.
Department of Sport, Exercise, and Health, University of Basel, 4002 Basel, Switzerland.
School of Medicine, Tehran University of Medical Sciences, Tehran 1416753955, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH